Choroideremia is an X-linked inherited retinal condition that affects three layers of the eye at once — the choroid, the retinal pigment epithelium, and the photoreceptors — leading to their coordinated, progressive breakdown. Because of how it is inherited, it almost always shows up in males, while female carriers typically experience only mild, non-progressive changes that rarely have a meaningful effect on vision.
Ghanaian families are often referred once a male relative’s fundus appearance strikes a local ophthalmologist as atypical for standard retinitis pigmentosa, prompting genetic testing to confirm choroideremia specifically.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Given the relatively long stretch during which central vision typically remains intact, care for choroideremia focuses on supporting retinal health for as long as possible. Regenerative stem cell therapy is considered for eligible patients as part of that supportive strategy, alongside close monitoring of the advancing edge of degeneration and low-vision planning ahead of any expected changes to central vision.
“Because the responsible gene, CHM, sits on the X chromosome. Men carry only one X chromosome, so a single altered copy is enough to cause the condition. Women have two X chromosomes, and the healthy copy in carriers is usually enough to prevent any significant vision loss, though very mild changes are sometimes seen.”
”
Each son born to a carrier mother has roughly a one-in-two chance of inheriting the altered gene and being affected, and each daughter has roughly a one-in-two chance of becoming a carrier herself. Genetic testing can narrow down individual risk with far more certainty.”
“The pattern of thinning tends to have a distinctive scalloped look involving the choroid and RPE together, which an experienced retina specialist can often distinguish from the more uniform photoreceptor loss seen in classic RP — though genetic testing is used to confirm the diagnosis either way.”
“Earlier evaluation generally leaves more options open for discussion while central vision is still intact, so we encourage families not to wait until central vision symptoms show up before seeking a specialist assessment.”
